Bioquark
Latest
Researchers will attempt to ‘reanimate’ a corpse with stem cells
Brain death may no longer be a life sentence if one Philadelphia-based biomedical startup has its way. The company, Bioquark, plans to initiate a study later this year to see if a combination of stem cell and protein blend injections, electrical nerve stimulation, and laser therapy can reverse the effects of recent brain death. They're literally trying to bring people back from the dead.
Biotech companies get permission to test brain death reversal
Brain death in humans is normally considered irreversible. Even if you keep the body running, those damaged brain cells just won't recover to the point where you get a fully functioning person again. However, that isn't stopping Dr. Himanshu Bansal and his partners at Bioquark and Revita Life Sciences. They recently received approval from American and Indian review boards to conduct a trial aimed at eventually reversing brain death in humans. The initial, months-long test will use multiple techniques to try and regenerate brains in 20 patients, including lasers, nerve stimulation and injections of both peptides as well as stem cells.